Literature DB >> 8035877

Prion protein is necessary for normal synaptic function.

J Collinge1, M A Whittington, K C Sidle, C J Smith, M S Palmer, A R Clarke, J G Jefferys.   

Abstract

The prion diseases are neurodegenerative conditions, transmissible by inoculation, and in some cases inherited as an autosomal dominant disorder. They include Creutzfeldt-Jakob disease in humans and scrapie and bovine spongiform encephalopathy in animals. The prion consists principally of a post-translationally modified form of a host-encoded glycoprotein (PrPC), designated PrPSc (ref. 1); the normal cellular function of PrPC is, however, unknown. Although PrP is highly conserved among mammals and widely expressed in early embryogenesis, mice homozygous for disrupted PrP genes appear developmentally and behaviourally normal. PrP is a protein anchored to the neuronal surface by glycosylphosphatidylinositol, suggesting a role in cell signalling or adhesion. Here we report that hippocampal slices from PrP null mice have weakened GABAA (gamma-aminobutyric acid type A) receptor-mediated fast inhibition and impaired long-term potentiation. This impaired synaptic inhibition may be involved in the epileptiform activity seen in Creutzfeldt-Jakob disease and we argue that loss of function of PrPC may contribute to the early synaptic loss and neuronal degeneration seen in these diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035877     DOI: 10.1038/370295a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  156 in total

1.  Normal prion protein has an activity like that of superoxide dismutase.

Authors:  D R Brown; B S Wong; F Hafiz; C Clive; S J Haswell; I M Jones
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

Review 2.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

Review 3.  Cellular prion protein: implications in seizures and epilepsy.

Authors:  Roger Walz; Rosa Maria R P S Castro; Tonicarlo R Velasco; Carlos G Carlotti; Américo C Sakamoto; Ricardo R Brentani; Vilma R Martins
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 4.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

5.  Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia.

Authors:  Eckhard Flechsig; Ivan Hegyi; Rainer Leimeroth; Armando Zuniga; Daniela Rossi; Antonio Cozzio; Petra Schwarz; Thomas Rülicke; Jürgen Götz; Adriano Aguzzi; Charles Weissmann
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

Review 6.  Prion protein at the crossroads of physiology and disease.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Ursula Unterberger; David A Harris
Journal:  Trends Neurosci       Date:  2011-12-01       Impact factor: 13.837

Review 7.  Prion potency in stem cells biology.

Authors:  Marilene H Lopes; Tiago G Santos
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

Review 8.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

9.  Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors.

Authors:  Haitao You; Shigeki Tsutsui; Shahid Hameed; Thomas J Kannanayakal; Lina Chen; Peng Xia; Jordan D T Engbers; Stuart A Lipton; Peter K Stys; Gerald W Zamponi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

10.  Prion protein expression and superoxide dismutase activity.

Authors:  D R Brown; A Besinger
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.